Patents by Inventor Douglas Luther

Douglas Luther has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8629249
    Abstract: A polypeptide, designated as “Streptococcus uberis Adhesion Molecule” (SUAM), and fragments of SUAM, prevent internalization and adherence of Streptococcus uberis and other streptococcal pathogens to cells. The SUAM polypeptide and fragments may be used diagnostically and therapeutically. Nucleic acid sequences encoding the SUAM polypeptide and fragments are included in the invention.
    Type: Grant
    Filed: June 7, 2010
    Date of Patent: January 14, 2014
    Assignee: University of Tennessee Research Foundation
    Inventors: Stephen P. Oliver, Raul A. Almeida, Douglas A. Luther, Hee-Myung Park
  • Patent number: 8412540
    Abstract: Methods and systems permit registration of a service provider and permit eligibility information to be provided to the service provider. Registration information is received over a financial network from a point-of-sale terminal. The registration information has an identifier associated with the point-of-sale terminal and an identification of the service provider. The identifier is associated with information identifying a device disposed at a location of the service provider in a database, permitting a communication path to the device to be established. A confirmation of registration of the point-of-sale terminal is transmitted to the device over the communication path.
    Type: Grant
    Filed: September 29, 2010
    Date of Patent: April 2, 2013
    Assignee: Alegeus Technologies, LLC
    Inventors: Jeffrey Jay Erdmann, Steven T. Brown, Joanne E. Gruchalski, Rosanne Marie Butkowski, Douglas Luther Norman, Henry Anthony Widenski, Jr., Jimmie Lindsey, Greg Leininger, Mark Andrew Neuville, Daniel L. Perry
  • Publication number: 20110106570
    Abstract: Methods and systems permit registration of a service provider and permit eligibility information to be provided to the service provider. Registration information is received over a financial network from a point-of-sale terminal. The registration information has an identifier associated with the point-of-sale terminal and an identification of the service provider. The identifier is associated with information identifying a device disposed at a location of the service provider in a database, permitting a communication path to the device to be established. A confirmation of registration of the point-of-sale terminal is transmitted to the device over the communication path.
    Type: Application
    Filed: September 29, 2010
    Publication date: May 5, 2011
    Applicant: Metavante Corporation
    Inventors: Jeffrey Jay Erdmann, Steven T. Brown, Joanne E. Gruchalski, Rosanne Marie Butkowski, Douglas Luther Norman, Henry Anthony Widenski, JR., Jimmie Lindsey, Greg Leininger, Mark Andrew Neuville, Daniel L. Perry
  • Publication number: 20100291132
    Abstract: A polypeptide, designated as “Streptococcus uberis Adhesion Molecule” (SUAM), and fragments of SUAM, prevent internalization and adherence of Streptococcus uberis and other streptococcal pathogens to cells. The SUAM polypeptide and fragments may be used diagnostically and therapeutically. Nucleic acid sequences encoding the SUAM polypeptide and fragments are included in the invention.
    Type: Application
    Filed: June 7, 2010
    Publication date: November 18, 2010
    Inventors: Stephen P. Oliver, Raul A. Almeida, Douglas A. Luther, Hee-Myung Park
  • Patent number: 7822624
    Abstract: Methods and systems permit registration of a service provider and permit eligibility information to be provided to the service provider. Registration information is received over a financial network from a point-of-sale terminal. The registration information has an identifier associated with the point-of-sale terminal and an identification of the service provider. The identifier is associated with information identifying a device disposed at a location of the service provider in a database, permitting a communication path to the device to be established. A confirmation of registration of the point-of-sale terminal is transmitted to the device over the communication path.
    Type: Grant
    Filed: July 26, 2006
    Date of Patent: October 26, 2010
    Assignee: Metavante Corporation
    Inventors: Jeffrey Jay Erdmann, Steven T. Brown, Joanne E. Gruchalski, Rosanne Marie Butkowski, Douglas Luther Norman, Henry Anthony Widenski, Jr., Jimmie Lindsey, Greg Leininger, Mark Andrew Neuville, Daniel L. Perry
  • Patent number: 7812147
    Abstract: A polypeptide, designated as “Streptococcus uberis Adhesion Molecule” (SUAM), and fragments of SUAM, prevent internalization and adherence of Streptococcus uberis and other streptococcal pathogens to cells. The SUAM polypeptide and fragments may be used diagnostically and therapeutically. Nucleic acid sequences encoding the SUAM polypeptide and fragments are included in the invention.
    Type: Grant
    Filed: April 2, 2009
    Date of Patent: October 12, 2010
    Assignee: University of Tennessee Research Foundation
    Inventors: Stephen P. Oliver, Raul A. Almeida, Douglas A. Luther, Hee-Myung Park
  • Publication number: 20090226480
    Abstract: A polypeptide, designated as “Streptococcus uberis Adhesion Molecule” (SUAM), and fragments of SUAM, prevent internalization and adherence of Streptococcus uberis and other streptococcal pathogens to cells. The SUAM polypeptide and fragments may be used diagnostically and therapeutically. Nucleic acid sequences encoding the SUAM polypeptide and fragments are included in the invention.
    Type: Application
    Filed: April 2, 2009
    Publication date: September 10, 2009
    Inventors: Stephen P. Oliver, Raul A. Almeida, Douglas A. Luther, Hee-Myung Park
  • Patent number: 7517955
    Abstract: A polypeptide, designated as “Streptococcus uberis Adhesion Molecule” (SUAM), and fragments of SUAM, prevent internalization and adherence of Streptococcus uberis and other streptococcal pathogens to cells. The SUAM polypeptide and fragments may be used diagnostically and therapeutically. Nucleic acid sequences encoding the SUAM polypeptide and fragments are included in the invention.
    Type: Grant
    Filed: October 22, 2003
    Date of Patent: April 14, 2009
    Assignee: University of Tennessee Research Foundation
    Inventors: Stephen P. Oliver, Raul A. Almeida, Douglas A. Luther, Hee-Myung Park
  • Publication number: 20080027863
    Abstract: Methods and systems permit registration of a service provider and permit eligibility information to be provided to the service provider. Registration information is received over a financial network from a point-of-sale terminal. The registration information has an identifier associated with the point-of-sale terminal and an identification of the service provider. The identifier is associated with information identifying a device disposed at a location of the service provider in a database, permitting a communication path to the device to be established. A confirmation of registration of the point-of-sale terminal is transmitted to the device over the communication path.
    Type: Application
    Filed: July 26, 2006
    Publication date: January 31, 2008
    Applicant: Metavante Corporation
    Inventors: Jeffrey Jay Erdmann, Steven T. Brown, Joanne E. Gruchalski, Rosanne Marie Butkowski, Douglas Luther Norman, Henry Anthony Widenski, Jimmie Lindsey, Greg Leininger, Mark Andrew Neuville, Daniel L. Perry
  • Publication number: 20070185280
    Abstract: Despite the frangibility of additive-free granules of brominated anionic styrenic polymer, it has been found possible by use of special mechanical processing to provide pellets of unadulterated brominated anionic styrenic polymer having a bromine content of at least about 50 wt % and in which at least about 70 wt % (preferably at least about 75 wt %) of the pellets are retained on a standard US No. 40 sieve and no more than about 30 wt % (preferably no more than about 25 wt %) are retained on a standard US No. 5 sieve. In preferred embodiments such pelletized anionic styrenic polymer is brominated anionic polystyrene having a bromine content of at least about 67 wt %, e.g., in the range of about 67 to about 71 wt %. Also preferred are pelletized brominated anionic styrenic polymers in which the melt flow index (ASTM D 1238-99) at 220° C., 2.16 kg is at least 4 g/10 min and preferably is at least 5 g/10 min.
    Type: Application
    Filed: May 20, 2004
    Publication date: August 9, 2007
    Applicant: ALBEMARLE CORPORATION
    Inventor: Douglas Luther
  • Publication number: 20070117904
    Abstract: Disclosed are flame retardant compositions comprised of (a) brominated anionic styrenic polymer, and (b) at least one polybrominated alpha-omega diphenylalkane having a total of at least 6 bromine atoms directly bonded to the phenyl rings and in the range of 1 to 6 carbon atoms in the alkylene group disposed between the phenyl groups, and specified flame retarded polymer compositions with which have been blended (a) and (b) individually or in combination.
    Type: Application
    Filed: January 22, 2007
    Publication date: May 24, 2007
    Applicant: ALBEMARLE CORPORATION
    Inventors: Luc Muylem, Samuel Thomas, Susan Landry, Douglas Luther
  • Publication number: 20050137311
    Abstract: Disclosed are flame retardant compositions comprised of (a) brominated anionic styrenic polymer, and (b) at least one polybrominated alpha-omega diphenylalkane having a total of at least 6 bromine atoms directly bonded to the phenyl rings and in the range of 1 to 6 carbon atoms in the alkylene group disposed between the phenyl groups, and specified flame retarded polymer compositions with which have been blended (a) and (b) individually or in combination.
    Type: Application
    Filed: December 19, 2003
    Publication date: June 23, 2005
    Inventors: Luc Muylem, Samuel Thomas, Susan Landry, Douglas Luther
  • Publication number: 20040253654
    Abstract: A polypeptide, designated as “Streptococcus uberis Adhesion Molecule” (SUAM), and fragments of SUAM, prevent internalization and adherence of Streptococcus uberis and other streptococcal pathogens to cells. The SUAM polypeptide and fragments may be used diagnostically and therapeutically. Nucleic acid sequences encoding the SUAM polypeptide and fragments are included in the invention.
    Type: Application
    Filed: October 22, 2003
    Publication date: December 16, 2004
    Inventors: Stephen P. Oliver, Raul A. Almeida, Douglas A. Luther, Hee-Myung Park